Information Library

Results for: Commercial Services - Market Access - Europe

In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions.  Search our library today.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Quintiles Backs Change to Marketing Mix as NHS Reforms Take Hold

    Press Release — READING, UK – 30 May, 2012 – Quintiles has released the first in a series of briefing papers looking at how market access strategies can

  • UK Market Access Insight Brief

    White Paper — May 30, 2012
    Insight Briefing series on Market Access in key European countries

  • UK Market Access Insight Brief

    Podcast — May 30, 2012
    Insight Briefing series on Market Access in key European countries

  • PharmaField awards 2010

    Media Coverage — May 17, 2010
    Quintles employees take top honours at prestigious PharmaField Awards

  • Bridging Cultures

    Case Study — May 9, 2010
    Takeda's growth strategy for Europe was to move into the Spanish market. Read how a Spanish team was assembled within a tight timeframe, with the help of Quintiles’ global and local reach, high profile in the marketplace, depth of experience and expertise.

  • NHS Motivating Patients

    Case Study — May 7, 2010
    In 2008, the NHS announced plans to offer free health checks for heart disease, stroke, diabetes and kidney disease. Learn why Quintiles was the right ally for the NHS to successfully launch this cardio risk assessment program.

  • QUINTILES AND MOVETIS ANNOUNCE STRATEGIC ALLIANCE

    Press Release — January 28, 2010 - Quintiles announced a strategic alliance with Movetis NV for commercialization of its new product, Resolor (prucalopride), in the U.K. and Germany.

Page 1 of 1 (7 results)

Subscribe to Email Based on Your Interests

Set preferences